Safe Pro Group: Frost reports 9.82% stake

Safe Pro Group Inc. (SPAI) received a Schedule 13G reporting that Frost Gamma Investments Trust and Dr. Phillip Frost together beneficially own 2,000,000 shares of Safe Pro Group common stock.

Available on EDGAR 09/14/2026 - 06:05 AM EDT Accepted by SEC EDGAR 09/14/2026 - 06:05 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Safe Pro Group Inc. (SPAI) received a Schedule 13G reporting that Frost Gamma Investments Trust and Dr. Phillip Frost together beneficially own 2,000,000 shares of Safe Pro Group common stock. This represents 9.82% of the company’s common shares outstanding as of August 14, 2026.

The reported position consists of 1,000,000 shares of common stock plus an option to purchase an additional 1,000,000 shares, all held by Frost Gamma Investments Trust. Voting and dispositive power over the 2,000,000 shares is reported on a shared basis, with no sole voting or dispositive power. The reporting persons state that they disclaim beneficial ownership except to the extent of any pecuniary interest.

Key Figures

Beneficially owned shares: 2,000,000 shares Percent of class: 9.82% Shares outstanding: 20,362,862 shares +4 more

7 metrics

Beneficially owned shares 2,000,000 shares Common stock of Safe Pro Group Inc. reported by Frost Gamma Investments Trust and Dr. Phillip Frost

Percent of class 9.82% Percentage of Safe Pro Group Inc. common stock outstanding represented by the 2,000,000 shares

Shares outstanding 20,362,862 shares Safe Pro Group Inc. common stock issued and outstanding as of August 14, 2026

Shares held directly 1,000,000 shares Common stock of Safe Pro Group Inc. held by Frost Gamma Investments Trust

Shares underlying option 1,000,000 shares Option to purchase Safe Pro Group Inc. common stock held by Frost Gamma Investments Trust

Shared voting power 2,000,000 shares Shares over which the reporting persons have shared power to vote or direct the vote

Shared dispositive power 2,000,000 shares Shares over which the reporting persons have shared power to dispose or direct the disposition

Key Terms

beneficial ownership, pecuniary interest, Joint Filing Agreement, Rule 13d-1(k), +2 more

6 terms

beneficial ownership financial

"The reporting person disclaims beneficial ownership of these securities, except to the extent"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of any pecuniary interest therein and this report shall not"

Joint Filing Agreement regulatory

"The Reporting Persons have entered into a Joint Filing Agreement, a copy of which"

Rule 13d-1(k) regulatory

"file this jointly in accordance with the provisions of Rule 13d-1(k) of the"

disclaims beneficial ownership financial

"The reporting person disclaims beneficial ownership of these securities, except to the extent"

Section 16 regulatory

"beneficial owner of these securities for purposes of Section 16 or for any other"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in SPAI does Dr. Phillip Frost report on this Schedule 13G?

Dr. Phillip Frost, together with Frost Gamma Investments Trust, reports beneficial ownership of 2,000,000 shares of Safe Pro Group Inc. common stock, representing 9.82% of the outstanding common shares as of August 14, 2026.

How many Safe Pro Group Inc. (SPAI) shares are outstanding according to this filing?

The filing states there were 20,362,862 shares of Safe Pro Group Inc. common stock issued and outstanding as of August 14, 2026, based on the company’s Form 10-Q for the quarter ended June 30, 2026.

How is the 2,000,000-share position in SPAI structured for Frost Gamma Investments Trust?

The reported 2,000,000-share position includes 1,000,000 shares of Safe Pro Group common stock and an option to purchase 1,000,000 shares, all held by Frost Gamma Investments Trust, with shared voting and dispositive power over the entire amount.

Does Dr. Phillip Frost have sole voting control over his SPAI holdings?

No. The filing reports 0 shares with sole voting power and 2,000,000 shares with shared voting power, indicating that all reported voting authority over the Safe Pro Group Inc. shares is shared rather than sole.

What disclaimer of ownership do the reporting persons make regarding SPAI stock?

The reporting persons state they disclaim beneficial ownership of the reported securities, except to the extent of any pecuniary interest, and that this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose.

Who are the reporting persons on this Schedule 13G for SPAI?

The Schedule 13G is filed on behalf of Frost Gamma Investments Trust and Dr. Phillip Frost, who have entered into a Joint Filing Agreement to file jointly under Rule 13d-1(k) of the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Safe Pro Group Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

78642D101

(CUSIP Number)

09/09/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 78642D101

1

Names of Reporting Persons

Phillip Frost, M.D.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,000,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,000,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,000,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.82 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) Includes 1,000,000 shares of Common Stock and the option to purchase 1,000,000 shares of Common Stock held by Frost Gamma Investments Trust ("FGIT"). Dr. Frost is the trustee of FGIT. Frost Gamma L.P. is the sole and exclusive beneficiary of FGIT. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (2) Based on 20,362,862 shares issued and outstanding as of August 14, 2026 as reported by the Issuer in its Form 10-Q for the quarterly period ending June 30, 2026.

SCHEDULE 13G

CUSIP Number(s): 78642D101

1

Names of Reporting Persons

Frost Gamma Investments Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,000,000.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,000,000.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,000,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.82 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: (1) Includes 1,000,000 shares of Common Stock and the option to purchase 1,000,000 shares of Common Stock held by Frost Gamma Investments Trust ("FGIT"). Dr. Frost is the trustee of FGIT. Frost Gamma L.P. is the sole and exclusive beneficiary of FGIT. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (2) Based on 20,362,862 shares issued and outstanding as of August 14, 2026 as reported by the Issuer in its Form 10-Q for the quarterly period ending June 30, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Safe Pro Group Inc.
(b)	Address of issuer's principal executive offices: 18305 Biscayne Blvd., Suite 222, Aventura, FL 33160
Item 2.
(a)	Name of person filing: This statement is filed on behalf of Frost Gamma Investments Trust ("FGIT") and Dr. Phillip Frost (together with FGIT, the "Reporting Persons"). The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934.
(b)	Address or principal business office or, if none, residence: Dr. Phillip Frost has a business address located at: 4400 Biscayne Boulevard, Miami, FL 33137 FGIT has a business address located at: 4400 Biscayne Boulevard, Miami, FL 33137
(c)	Citizenship: Dr. Phillip Frost is a citizen of the United States and FGIT is established in the State of Florida
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 78642D101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,000,000
(b)	Percent of class: 9.82 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 2,000,000
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 2,000,000
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Phillip Frost, M.D.

Signature:	/s/ Phillip Frost, MD
Name/Title:	Phillip Frost, MD
Date:	09/14/2026

Frost Gamma Investments Trust

Signature:	/s/ Phillip Frost, M.D
Name/Title:	Trustee
Date:	09/14/2026

Exhibit Information

Joint Filing Agreement with Phillip Frost, M.D. and Frost Gamma Investments Trust, dated September 9, 2026.